15. Medable
Summary
Many studies have confirmed that clinical trials remain more white than they should be relative to population statistics, and in many cases under-represent not just racial and ethnic groups but women and the elderly. Inequality in the world of clinical trials isnt new, but the Covid-19 vaccine effort highlighted the issue in a way it had not previously received widespread public scrutiny. Over the course of the pandemic, Medable decentralized more than 150 clinical trials to over one million participants across 41 countries and in over 60 languages, including Covid-19 vaccine and therapeutic treatment. By the end of 2022, Medable expects to boost its access to patients by 100 times, with a consumer strategy that it says "removes the barrier between research and everyday life." The stakes are high for participants and disease sufferers, researchers who need data to make the right medical decisions, and regulators who approve drug and device breakthroughs.